Impact of Dosing Weight on Clinical Outcomes in Obese Patients Receiving Acyclovir for HSV Encephalitis (ID-OPRAH)
Condition:   HSV Encephalitis Intervention:   Other: To assess the clinical impact of dosing acyclovir based on IBW or adjBW for HSV encephalitis to definitively guide safe and effective therapy. Sponsor:   Methodist Health System Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2021 Category: Research Source Type: clinical trials